Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Lancet
    June 2024
  1. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    >> Share

  2. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    >> Share

  3. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    >> Share

  4. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    >> Share

  5. SCHRECKER T
    Canada's reckoning?
    Lancet. 2024;403:2688.
    >> Share

  6. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    >> Share

  7. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    >> Share

  8. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    >> Share

  9. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    >> Share

  10. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    >> Share

  11. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    >> Share

  12. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    >> Share

  13. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    >> Share

  14. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    >> Share

  15. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    >> Share

  16. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    >> Share

  17. MOHAPATRA PR
    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    >> Share

  18. ANIRVAN P
    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    >> Share

  19. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    >> Share

  20. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    >> Share

  21. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    >> Share

  22. HORTON R
    Offline: UK election-two issues you won't hear about.
    Lancet. 2024;403:2362.
    >> Share

    May 2024
  23. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    >> Share

  24. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    >> Share

  25. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    >> Share

  26. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    >> Share

  27. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    >> Share

  28. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    >> Share

  29. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    >> Share

  30. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    >> Share

  31. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    >> Share

  32. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    >> Share

  33. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    >> Share

  34. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    >> Share

  35. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    >> Share

  36. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    >> Share

  37. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    >> Share

  38. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    >> Share

  39. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    >> Share

  40. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    >> Share

  41. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    >> Share

    April 2024
  42. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    >> Share

  43. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    >> Share

  44. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    >> Share


  45. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    >> Share

  46. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    >> Share

  47. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    >> Share

  48. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    >> Share

  49. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    >> Share

  50. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    >> Share

  51. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    >> Share

  52. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    >> Share

  53. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    >> Share

  54. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    >> Share


  55. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    >> Share

    March 2024
  56. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    >> Share

  57. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    >> Share

  58. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    >> Share


  59. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    >> Share

  60. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    >> Share

    February 2024
  61. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    >> Share

  62. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    >> Share

  63. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    >> Share

  64. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    >> Share

  65. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    >> Share

  66. WANG X, Li Y, Shi T, Bont LJ, et al
    Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
    >> Share

  67. ADERINTO N, Olatunji G, Kokori E
    Health implications of GSK's departure from Nigeria.
    Lancet. 2024;403:526-527.
    >> Share

    January 2024
  68. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
    The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
    >> Share

  69. WANG L, Wang Q, Gao GF
    Interpreting COVID-19 data from China: a call for caution - Authors' reply.
    Lancet. 2024;403:144-145.
    >> Share

  70. QU Z
    Interpreting COVID-19 data from China: a call for caution.
    Lancet. 2024;403:144.
    >> Share

  71. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    >> Share


  72. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
    >> Share

  73. SHAH SA, Robertson C, Sheikh A
    Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
    Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
    >> Share

    December 2023
  74. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
    Louis Pasteur, COVID-19, and the social challenges of epidemics.
    Lancet. 2023;400:2166-2168.
    >> Share

  75. CHARLIER P
    Death and end of life in France after COVID-19.
    Lancet. 2023;402:2290.
    >> Share

  76. HORTON R
    Offline: Boris Johnson and COVID-19-more light than heat.
    Lancet. 2023;402:2277.
    >> Share

    November 2023
  77. GRABAR-KITAROVIC K, Phumaphi J
    A crisis of trust in pandemic prevention, preparedness, and response.
    Lancet. 2023;402:1730-1732.
    >> Share

  78. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    >> Share

  79. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    >> Share


  80. Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    >> Share

  81. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    >> Share

  82. MARTIN A, Jamieson S
    Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    >> Share

  83. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
    Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    >> Share

  84. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    >> Share

  85. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
    Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    >> Share

  86. HAZIR SG, Ryan C, Moore A, Lewis C, et al
    The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    >> Share

  87. DU Z, Wang L, Bai Y, Pei Y, et al
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    >> Share

  88. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
    Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    >> Share

    October 2023
  89. WANG Q, Bowen A, Ho J, Zhang RM, et al
    SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
    Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
    >> Share

  90. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
    Scientific advisory councils in the COVID-19 response.
    Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
    >> Share

    September 2023
  91. MATUCHANSKY C
    Natural SARS-CoV-2 infection-induced immune protection against re-infection.
    Lancet. 2023;402:1131.
    >> Share

  92. FLACCO ME, Martellucci CA, Manzoli L
    Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Lancet. 2023;402:1129.
    >> Share

  93. YANG C, Lapp L, Tebbutt SJ
    Overcoming COVID-19 vaccine hesitancy hurdles.
    Lancet. 2023;402:1129-1130.
    >> Share

  94. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
    Striving to afford free health care in Greece during COVID-19.
    Lancet. 2023;402:1128-1129.
    >> Share

  95. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
    Long COVID in low-income and middle-income countries: the hidden public health crisis.
    Lancet. 2023;402:1115-1117.
    >> Share

  96. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
    Lancet. 2023;402:1132.
    >> Share

  97. QU Z
    Cautionary notes on the COVID-19 re-infection study.
    Lancet. 2023;402:1130-1131.
    >> Share

  98. ZHOU YB, Xu ZG
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
    Lancet. 2023;402:1131-1132.
    >> Share

  99. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
    Community COVID-19 response in WHO's European region.
    Lancet. 2023;402:1127.
    >> Share

  100. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    >> Share

  101. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    >> Share

  102. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    >> Share

    August 2023
  103. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    >> Share

  104. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    >> Share

  105. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    >> Share

  106. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    >> Share

    July 2023
  107. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    >> Share

  108. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    >> Share

  109. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    >> Share

    June 2023
  110. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
    Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
    Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
    >> Share


  111. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    >> Share

  112. PELOSI A
    Disrespectful language about patients with long COVID.
    Lancet. 2023;401:2108.
    >> Share

  113. PRIYA GIRI S, Dubey A
    Loneliness in the time of COVID-19: an alarming rise.
    Lancet. 2023;401:2107-2108.
    >> Share

  114. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
    Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
    Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
    >> Share

  115. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
    Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
    Lancet. 2023;401:2021-2023.
    >> Share

  116. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    >> Share

  117. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    >> Share

  118. LAL A, Schwalbe N
    Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery.
    Lancet. 2023;401:1847.
    >> Share

    May 2023
  119. JAFFE S
    US health experts divided on social media age restrictions.
    Lancet. 2023;401:1757.
    >> Share


  120. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
    Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
    >> Share

  121. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    >> Share

  122. ZAROCOSTAS J
    With the COVID-19 PHEIC over, what next?
    Lancet. 2023;401:1642-1643.
    >> Share

  123. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
    Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
    Lancet. 2023;401:1649.
    >> Share

  124. JAFFE S
    US Surgeon General: loneliness is a public health crisis.
    Lancet. 2023;401:1560.
    >> Share

  125. EMANUEL EJ, Persad G
    The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
    Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
    >> Share

    April 2023
  126. AGRAWAL U, Robertson C, Sheikh A
    Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
    Lancet. 2023;401:1424.
    >> Share

  127. BRANCH-ELLIMAN W, Monach PA
    Moving towards a precision approach for prevention of severe COVID-19.
    Lancet. 2023;401:1423-1424.
    >> Share

  128. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
    The importance of accountability in tackling future pandemics.
    Lancet. 2023;401:1423.
    >> Share

  129. GALVAO J
    COVID-19: forgetting a pandemic that is not over.
    Lancet. 2023;401:1422-1423.
    >> Share

  130. THE LANCET
    Moving past the COVID-19 emergency in the USA.
    Lancet. 2023;401:1399.
    >> Share

  131. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
    Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
    >> Share

  132. CUENI T
    Lessons learned from COVID-19 to stop future pandemics.
    Lancet. 2023;401:1340.
    >> Share

  133. HORTON R
    Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
    Lancet. 2023;401:1324.
    >> Share

  134. LURIE N, Sharfstein JM
    State-to-state differences in US COVID-19 outcomes: searching for explanations.
    Lancet. 2023;401:1314-1315.
    >> Share

  135. BILLARD MN, Bont LJ
    The link between respiratory syncytial virus infection during infancy and asthma during childhood.
    Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
    >> Share

  136. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
    Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
    Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
    >> Share

  137. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
    Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
    Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
    >> Share

  138. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
    Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
    Lancet. 2023;401:e20.
    >> Share

  139. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
    Characteristics of the omicron XBB subvariant wave in Singapore.
    Lancet. 2023;401:1261-1262.
    >> Share

  140. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
    Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
    Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
    >> Share


  141. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
    >> Share

  142. PERNER A, Venkatesh B
    Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
    Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
    >> Share

    March 2023
  143. SUN L, Jia H, Yang T
    Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1000.
    >> Share

  144. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
    Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
    >> Share

  145. QU Z
    International cooperation to end the COVID-19 pandemic.
    Lancet. 2023;401:820.
    >> Share

  146. THE LANCET
    Long COVID: 3 years in.
    Lancet. 2023;401:795.
    >> Share


  147. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    Lancet. 2023;401:833-842.
    >> Share

  148. COHEN C, Pulliam J
    COVID-19 infection, reinfection, and the transition to endemicity.
    Lancet. 2023;401:798-800.
    >> Share

  149. STOCKWELL M
    Effect of a nationwide intervention of electronic letters with behavioural nudges on influenza vaccination in older adults in Denmark.
    Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453.
    >> Share

  150. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
    Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349.
    >> Share

  151. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
    Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
    Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
    >> Share

    February 2023
  152. HUANG S, Gao Z, Wang S
    China's COVID-19 reopening measures-warriors and weapons.
    Lancet. 2023;401:643-644.
    >> Share

  153. HAY SI, Murray CJL
    Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Lancet. 2023;401:433-434.
    >> Share

  154. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432-433.
    >> Share

  155. DONZELLI A
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432.
    >> Share

  156. MOETI M, Makubalo L, Gueye AS, Balde T, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  157. O'NEILL D
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  158. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431-432.
    >> Share

  159. PAN Y, Wang L, Feng Z, Xu H, et al
    Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
    >> Share

  160. PREISER W, Maponga T
    So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
    Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
    >> Share

  161. TAN H, Liu J, Zeng F
    China needs a scientific long COVID recovery-support platform.
    Lancet. 2023;401:344-345.
    >> Share

    January 2023
  162. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
    Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
    >> Share

  163. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
    Global and regional governance of One Health and implications for global health security.
    Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
    >> Share

  164. TRAORE T, Shanks S, Haider N, Ahmed K, et al
    How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
    Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
    >> Share

  165. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
    A global analysis of One Health Networks and the proliferation of One Health collaborations.
    Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
    >> Share

  166. ELLINGTON S, Jatlaoui TC
    COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
    Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
    >> Share

  167. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
    Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
    >> Share

  168. THE LANCET
    The COVID-19 pandemic in 2023: far from over.
    Lancet. 2023;401:79.
    >> Share

  169. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
    COVID-19 and other pandemics require a coherent response strategy.
    Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
    >> Share

    December 2022
  170. TIBBLE H, Mueller T, Proud E, Hall E, et al
    Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
    Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
    >> Share

  171. KIDD MR, Kelly PM
    PANORAMIC: important insights into molnupiravir use in COVID-19.
    Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
    >> Share

  172. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
    Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
    >> Share

  173. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
    Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
    Lancet. 2022;400:2109-2124.
    >> Share

  174. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
    Racism, xenophobia, discrimination, and the determination of health.
    Lancet. 2022;400:2097-2108.
    >> Share

  175. ELSON W, Zambon M, de Lusignan S
    Integrated respiratory surveillance after the COVID-19 pandemic.
    Lancet. 2022;400:1924-1925.
    >> Share

    November 2022
  176. JAFFE S
    US CDC begins agency-wide changes after pandemic failures.
    Lancet. 2022;400:1754-1755.
    >> Share

  177. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    >> Share

  178. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
    Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
    Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
    >> Share

  179. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
    WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
    >> Share

  180. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    >> Share

    October 2022

  181. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
    >> Share

  182. FRENK J, Chen LC, Chandran L, Groff EOH, et al
    Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
    Lancet. 2022;400:1539-1556.
    >> Share

  183. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
    >> Share

  184. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
    The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
    Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
    >> Share

  185. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
    After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
    Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
    >> Share

  186. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
    Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2022;400:1305-1320.
    >> Share

  187. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
    Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
    Lancet. 2022;400:1304.
    >> Share

  188. IRVING SA, Sundaram ME
    Prioritisation of COVID-19 boosters in the omicron era.
    Lancet. 2022;400:1282-1283.
    >> Share

  189. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    >> Share

  190. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    >> Share

  191. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
    A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
    Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
    >> Share

  192. WU MY, Carr EJ, Harvey R, Mears HV, et al
    WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
    Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
    >> Share

    September 2022
  193. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
    Characterising adults in Scotland who are not vaccinated against COVID-19.
    Lancet. 2022;400:993-995.
    >> Share

  194. ZIEGLER T, Moen A, Zhang W, Cox NJ, et al
    Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected.
    Lancet. 2022;400:981-982.
    >> Share

  195. THE LANCET
    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    >> Share

  196. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    >> Share

  197. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    >> Share

  198. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    >> Share

  199. ZHANG Y, Wang Y, Ning G, He P, et al
    Protecting older people: a high priority during the COVID-19 pandemic.
    Lancet. 2022;400:729-730.
    >> Share

  200. THORNTON J
    New centre for pandemic therapeutics.
    Lancet. 2022;400:722.
    >> Share

    August 2022
  201. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Influenza.
    Lancet. 2022;400:693-706.
    >> Share

  202. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    >> Share

  203. PICKERSGILL M, Manda-Taylor L, Nino-Machado N
    Pandemic preparedness means policy makers need to work with social scientists.
    Lancet. 2022;400:547-549.
    >> Share

  204. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    >> Share

  205. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    >> Share

  206. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    >> Share

  207. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    >> Share

    July 2022

  208. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

  209. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  210. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share

  211. DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
    Bronchiolitis.
    Lancet. 2022;400:392-406.
    >> Share

  212. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    >> Share

  213. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    >> Share

  214. DURRHEIM DN
    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  215. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    >> Share

  216. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share

  217. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share

  218. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    >> Share

  219. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    >> Share

    June 2022
  220. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    >> Share

  221. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    >> Share

  222. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    >> Share

  223. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    >> Share

  224. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    >> Share

  225. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    >> Share

  226. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    >> Share

  227. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    >> Share

  228. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    >> Share

    May 2022
  229. HARTERT TV, Ortiz JR
    Need for improved global measurement of early childhood respiratory syncytial virus disease.
    Lancet. 2022;399:1993-1995.
    >> Share

  230. LI Y, Wang X, Blau DM, Caballero MT, et al
    Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Lancet. 2022;399:2047-2064.
    >> Share

  231. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    >> Share

  232. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    >> Share

  233. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    >> Share

  234. HORTON R
    Offline: How to fix pandemic preparedness.
    Lancet. 2022;399:1927.
    >> Share

  235. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    >> Share

  236. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    >> Share

  237. SHERLOCK PL
    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    >> Share

  238. THE LANCET
    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    >> Share

  239. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    >> Share

  240. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    >> Share

  241. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    >> Share

  242. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    >> Share


  243. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    >> Share

    April 2022
  244. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    >> Share

  245. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    >> Share

  246. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    >> Share

  247. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    >> Share

  248. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    >> Share

  249. NTOUMI F, Zumla A
    Advancing accurate metrics for future pandemic preparedness.
    Lancet. 2022;399:1443-1445.
    >> Share

  250. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    >> Share

  251. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    >> Share

  252. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    >> Share

  253. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    >> Share


  254. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    >> Share

  255. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    >> Share

  256. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    >> Share

  257. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    >> Share

  258. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    >> Share

  259. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    >> Share

  260. ZAROCOSTAS J
    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    >> Share

  261. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    >> Share

  262. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    >> Share

    March 2022
  263. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    >> Share

  264. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    >> Share

  265. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    >> Share


  266. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    >> Share

  267. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    >> Share

  268. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    >> Share

  269. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

  270. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    >> Share

  271. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    >> Share

  272. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    >> Share

  273. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    >> Share

  274. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    >> Share

  275. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    >> Share

  276. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    >> Share


  277. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    >> Share

  278. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    >> Share

  279. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    >> Share

  280. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    >> Share

  281. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    >> Share

  282. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    >> Share

    February 2022
  283. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    >> Share

  284. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    >> Share

  285. THE LANCET
    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    >> Share


  286. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    >> Share

  287. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    >> Share

  288. PIECHOTTA V, Harder T
    Waning of COVID-19 vaccine effectiveness: individual and public health risk.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
    >> Share

  289. FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
    Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
    >> Share

  290. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    >> Share

  291. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    >> Share

  292. DINEEN K, Autzen B, Alwan NA
    Children, intersectionality, and COVID-19.
    Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
    >> Share

  293. SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
    Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
    Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
    >> Share

  294. EGGER S, Egger G
    The vaccinated propor-tion of people with COVID-19 needs context.
    Lancet. 2022;399:627.
    >> Share

  295. MUSSINI C, Cozzi-Lepri A
    Another piece in the COVID-19 treatment puzzle.
    Lancet. 2022;399:609-610.
    >> Share

  296. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    >> Share


  297. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2022;399:665-676.
    >> Share

  298. LOPEZ A, Srigley J
    Transmission of SARS-CoV-2: still up in the air.
    Lancet. 2022;399:519.
    >> Share

  299. GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
    Transmission of SARS-CoV-2: still up in the air - Authors' reply.
    Lancet. 2022;399:519-520.
    >> Share

  300. DALY M, Robinson E
    Depression and anxiety during COVID-19.
    Lancet. 2022;399:518.
    >> Share

  301. SANTOMAURO DF, Whiteford HA, Ferrari AJ
    Depression and anxiety during COVID-19 - Authors' reply.
    Lancet. 2022;399:518-519.
    >> Share

  302. SAMARASEKERA U
    Ayoade Alakija: advancing equity in the COVID-19 response.
    Lancet. 2022;399:511.
    >> Share

  303. ZAROCOSTAS J
    WHO concerned over COVID-19 health-care waste.
    Lancet. 2022;399:507.
    >> Share

  304. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    >> Share

  305. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    >> Share

  306. THE LANCET
    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    >> Share

  307. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

  308. NORDSTROM P, Ballin M, Nordstrom A
    Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
    >> Share

  309. KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
    COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
    >> Share


  310. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
    >> Share

    January 2022
  311. HOLT E
    Polish Government COVID-19 advisors resign.
    Lancet. 2022;399:424.
    >> Share

  312. NEALON J, Cowling BJ
    Omicron severity: milder but not mild.
    Lancet. 2022;399:412-413.
    >> Share

  313. ADAMS R
    Urgent care: disability, pandemic, and the value of a life.
    Lancet. 2022;399:430-431.
    >> Share

  314. JAFFE S
    The next steps for US vaccine mandates.
    Lancet. 2022;399:425-426.
    >> Share

  315. SO-OSMAN C, Valk SJ
    High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
    >> Share


  316. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
    >> Share

  317. HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
    Measles.
    Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
    >> Share

  318. FENDLER A, Shepherd STC, Au L, Wu M, et al
    Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
    >> Share

  319. TANG TB
    The COVID-19 response in Hong Kong.
    Lancet. 2022;399:357.
    >> Share

  320. ALFIERI C, Egrot M, Desclaux A, Sams K, et al
    Recognising Italy's mistakes in the public health response to COVID-19.
    Lancet. 2022;399:357-358.
    >> Share

  321. QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
    Intersectionality and developing evidence-based policy.
    Lancet. 2022;399:355-356.
    >> Share

  322. BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
    Long COVID and self-management.
    Lancet. 2022;399:355.
    >> Share

  323. LANE R
    Jamal Rifi: family doctor building bridges in the community.
    Lancet. 2022;399:353.
    >> Share

  324. COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
    Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
    >> Share

  325. BRAVO L, Smolenov I, Han HH, Li P, et al
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
    >> Share

  326. VESIKARI T
    Trimeric S protein COVID-19 vaccine needs to find its place.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
    >> Share

  327. CARR EJ, Wu M, Harvey R, Billany RE, et al
    Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
    >> Share

  328. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    >> Share

  329. MURRAY CJL
    COVID-19 will continue but the end of the pandemic is near.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
    >> Share

  330. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    >> Share

  331. KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
    Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
    >> Share

  332. LAXMINARAYAN R
    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    >> Share

  333. VALAIYAPATHI R, Wu MS, McGregor A
    Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
    Lancet. 2022;399:270.
    >> Share

  334. PUNTIS JWL
    The UK People's Covid Inquiry.
    Lancet. 2022;399:236.
    >> Share

  335. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

  336. HARMAN S
    The wall.
    Lancet. 2022;399:136-137.
    >> Share

  337. BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
    COVID-19 ARDS: getting ventilation right - Authors' reply.
    Lancet. 2022;399:22-23.
    >> Share

  338. PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
    COVID-19 ARDS: getting ventilation right.
    Lancet. 2022;399:22.
    >> Share

  339. HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
    Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
    Lancet. 2022;399:21-22.
    >> Share

  340. THE LANCET
    The state of science and society in 2022.
    Lancet. 2022;399:1.
    >> Share

    December 2021
  341. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
    >> Share

  342. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    >> Share

  343. KENNEDY RB
    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
    >> Share

  344. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
    >> Share

  345. LEUNG K, Wu JT
    Managing waning vaccine protection against SARS-CoV-2 variants.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
    >> Share

  346. KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
    Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
    >> Share

  347. DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
    Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
    >> Share

  348. PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
    Diagnostics for COVID-19: moving from pandemic response to control.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
    >> Share

  349. THE LANCET
    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    >> Share

  350. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    >> Share

  351. DANIELS JP
    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    >> Share

  352. HALL V, Hopkins S
    COV-BOOST: evidence to support rapid booster deployment.
    Lancet. 2021;398:2209-2211.
    >> Share

  353. THE LANCET
    COVID-19: where do we go from here?
    Lancet. 2021;398:2207.
    >> Share

  354. MOLLICA RF, Fricchione GL
    Mental and physical exhaustion of health-care practitioners.
    Lancet. 2021;398:2243-2244.
    >> Share

  355. ZAROCOSTAS J
    WHO and World Bank urge spending for UHC.
    Lancet. 2021;398:2223.
    >> Share

  356. DEVI S
    Russia-Ukraine tensions hampering health-care access.
    Lancet. 2021;398:2222.
    >> Share

  357. COVIDSURG COLLABORATIVE
    Projecting COVID-19 disruption to elective surgery.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
    >> Share

  358. MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
    COVID-19 vaccine strategies must focus on severe disease and global equity.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
    >> Share

  359. BRADBURY CA, McQuilten Z
    Anticoagulation in COVID-19.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
    >> Share

  360. RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
    >> Share

  361. LIPWORTH B, Chan R, Misirovs R
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2147.
    >> Share

  362. HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
    High-dose budesonide for early COVID-19 - Authors' reply.
    Lancet. 2021;398:2147-2148.
    >> Share

  363. BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2146-2147.
    >> Share

  364. THE LANCET
    Preventing violence against women: beyond 16 days.
    Lancet. 2021;398:2125.
    >> Share

  365. MOON S, Armstrong J, Hutler B, Upshur R, et al
    Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
    Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
    >> Share

  366. RICHARDSON CD
    Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
    >> Share

  367. STUART ASV, Shaw RH, Liu X, Greenland M, et al
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
    >> Share

  368. DEVI S
    Health warnings over UNRWA funding shortfall.
    Lancet. 2021;398:2063.
    >> Share

  369. ZAROCOSTAS J
    Hope for nutrition summit as global hunger spikes.
    Lancet. 2021;398:2061-2062.
    >> Share

  370. WARD H, Flower B, Garcia PJ, Ong SWX, et al
    Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
    Lancet. 2021;398:2057-2059.
    >> Share

  371. KARIM SSA, Karim QA
    Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
    >> Share

  372. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    >> Share

  373. MUNRO APS, Janani L, Cornelius V, Aley PK, et al
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
    >> Share

    November 2021
  374. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    >> Share

  375. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    COVID-19 and myocardial infarction - Authors' reply.
    Lancet. 2021;398:1964.
    >> Share

  376. SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
    Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Lancet. 2021;398:1963.
    >> Share

  377. CALDEIRA D, Pinto FJ
    COVID-19 and myocardial infarction.
    Lancet. 2021;398:1963-1964.
    >> Share

  378. BOUM Y
    Beyond COVID-19: scaling up and sustaining mobile health in Africa.
    Lancet. 2021;398:1962-1963.
    >> Share

  379. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    >> Share

  380. SMITH K, Brooks W, Challiner J, Povey E, et al
    Quality assurance of remote clinical assessments in the NHS.
    Lancet. 2021;398:1962.
    >> Share

  381. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

  382. FLEMING KA, Horton S, Wilson ML, Atun R, et al
    The Lancet Commission on diagnostics: transforming access to diagnostics.
    Lancet. 2021;398:1997-2050.
    >> Share

  383. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    >> Share

  384. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    >> Share

  385. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    >> Share

  386. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    >> Share

  387. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    >> Share

  388. KNEEBONE R, Houstoun W, Houghton N
    Medicine, magic, and online performance.
    Lancet. 2021;398:1868-1869.
    >> Share

  389. BURKI T
    mRNA discoveries earn the 2021 Prince Mahidol Award.
    Lancet. 2021;398:1865.
    >> Share

  390. SPYROPOULOS AC, Bonaca MP
    Studying the coagulopathy of COVID-19.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
    >> Share


  391. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
    >> Share

  392. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    >> Share

  393. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    >> Share

  394. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    >> Share

  395. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    >> Share

  396. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    >> Share

  397. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    >> Share

  398. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.
    >> Share

  399. MCMULLEN AM
    The choice to love.
    Lancet. 2021;398:1680-1681.
    >> Share

  400. USHER AD
    New budget and strategy for ACT-A.
    Lancet. 2021;398:1677.
    >> Share

  401. ZAROCOSTAS J
    WHO's Tedros set to be re-elected unopposed.
    Lancet. 2021;398:1676.
    >> Share

  402. THE LANCET
    Can digital technologies improve health?
    Lancet. 2021;398:1663.
    >> Share

  403. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    >> Share

  404. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    >> Share

    October 2021
  405. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.
    >> Share

  406. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.
    >> Share

  407. DANIELS JP
    Nicaraguan health-care workers under attack.
    Lancet. 2021;398:1555-1556.
    >> Share

  408. BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
    The World Health Network: a global citizens' initiative.
    Lancet. 2021;398:1567-1568.
    >> Share

  409. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    >> Share

  410. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    >> Share

  411. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
    >> Share

  412. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    >> Share

  413. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.
    >> Share

  414. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.
    >> Share

  415. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.
    >> Share


  416. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.
    >> Share

  417. RICCIARDI W, Tarricone R
    The evolution of the Italian National Health Service.
    Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
    >> Share

  418. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
    >> Share

  419. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share

  420. LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
    Lancet. 2021;398:1304.
    >> Share

  421. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
    Lancet. 2021;398:1303-1304.
    >> Share

  422. MYERS SS, Pivor JI, Saraiva AM
    The Sao Paulo Declaration on Planetary Health.
    Lancet. 2021;398:1299.
    >> Share

  423. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
    >> Share


  424. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    >> Share

  425. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
    >> Share

  426. KLEINERT S, Horton R
    Can COVID-19 help accelerate and transform the diagnostics agenda?
    Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
    >> Share

  427. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    >> Share

  428. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    >> Share

  429. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
    >> Share

  430. TORRES I, Profeta B, Machado CV, Artaza O, et al
    COVID-19 research in LMICs - Authors' reply.
    Lancet. 2021;398:1213.
    >> Share

  431. SISA I, Fornasini M, Teran E
    COVID-19 research in LMICs.
    Lancet. 2021;398:1212-1213.
    >> Share

  432. VUYLSTEKE A
    ECMO in COVID-19: do not blame the tool.
    Lancet. 2021;398:1197-1199.
    >> Share

  433. BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
    Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
    Lancet. 2021;398:1230-1238.
    >> Share

  434. VINER RM, Koirala A
    Daily antigen testing to reduce disruption when schools return.
    Lancet. 2021;398:1196-1197.
    >> Share

    September 2021
  435. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
    >> Share

  436. THE LANCET
    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.
    >> Share

  437. AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
    Functioning of the International Health Regulations during the COVID-19 pandemic.
    Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
    >> Share

  438. OGBUOJI O, Mao W, Aryeetey G
    The long-term impact of COVID-19 on development assistance for health is still uncertain.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
    >> Share


  439. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
    >> Share

  440. WU Z, Jin Q, Wu G, Lu J, et al
    SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
    >> Share

  441. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    >> Share

  442. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    >> Share

  443. SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
    Uncoupling vaccination from politics: a call to action.
    Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
    >> Share

  444. YOUNG BC, Eyre DW, Kendrick S, White C, et al
    Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
    >> Share

  445. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    >> Share

  446. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    >> Share

  447. DANIELS JP
    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.
    >> Share

  448. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    >> Share

  449. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    >> Share

  450. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    >> Share

  451. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    >> Share

  452. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.
    >> Share

  453. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    >> Share

  454. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    >> Share

    August 2021
  455. THE LANCET
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    >> Share

  456. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    >> Share

  457. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    >> Share

  458. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    >> Share

  459. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    >> Share

  460. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    >> Share

  461. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    >> Share

  462. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    >> Share

  463. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    >> Share

  464. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    >> Share

  465. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    >> Share

  466. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    >> Share

  467. LIJFERING WM
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    >> Share

  468. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    >> Share

  469. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    >> Share

  470. ADEPOJU P
    West Africa on alert for haemorrhagic fevers.
    Lancet. 2021;398:653.
    >> Share

  471. USHER AD
    Health leaders criticise limited ACT-A review.
    Lancet. 2021;398:650-651.
    >> Share

  472. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    >> Share


  473. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    >> Share

  474. THORNTON J
    Focusing on island health.
    Lancet. 2021;398:569-570.
    >> Share

  475. DANIELS JP
    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    >> Share

  476. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    >> Share

  477. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    >> Share

  478. ETIENNE CF
    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    >> Share

  479. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    >> Share

  480. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    >> Share

  481. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    >> Share

  482. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    >> Share

  483. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    >> Share

  484. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    >> Share

  485. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    >> Share

  486. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    >> Share

  487. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    >> Share

  488. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    >> Share

  489. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    >> Share

  490. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  491. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    >> Share

  492. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    >> Share

  493. BELDA-INIESTA C
    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    >> Share

  494. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    >> Share

  495. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    >> Share

    July 2021
  496. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share

  497. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  498. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  499. IJSSELMUIDEN C, Ntoumi F, Lavery JV, Montoya J, et al
    Should global financing be the main priority for pandemic preparedness?
    Lancet. 2021;398:388.
    >> Share

  500. THE LANCET
    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.
    >> Share

  501. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share

  502. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    >> Share

  503. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    >> Share

  504. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.
    >> Share

  505. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.
    >> Share

  506. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.
    >> Share

  507. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.
    >> Share

  508. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    >> Share

  509. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    >> Share

  510. THE LANCET
    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.
    >> Share

  511. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    >> Share

  512. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    >> Share

  513. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    >> Share

  514. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    >> Share

  515. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.
    >> Share

  516. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.
    >> Share

  517. IDROVO AJ
    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.
    >> Share

  518. THE LANCET
    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    >> Share

  519. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    >> Share

  520. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
    >> Share

  521. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    >> Share

  522. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    >> Share

  523. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    WHO COVID-19 therapeutic guidelines - Authors' reply.
    Lancet. 2021;398:118.
    >> Share

  524. ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
    WHO COVID-19 therapeutic guidelines.
    Lancet. 2021;398:117-118.
    >> Share

  525. ALSABA K
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
    Lancet. 2021;398:116.
    >> Share

  526. NABETH P, Hassan M, Adib K, Abubakar A, et al
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
    Lancet. 2021;398:116-117.
    >> Share

  527. THE LANCET
    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    >> Share

  528. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.
    >> Share

  529. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.
    >> Share

  530. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    >> Share

  531. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    >> Share

  532. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
    >> Share

  533. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    >> Share

  534. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    >> Share

  535. THORNTON J
    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    >> Share

  536. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    >> Share

  537. THE LANCET
    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    >> Share

  538. KICKBUSCH I, Leung GM, Shattock RJ
    Learning from crisis: building resilient systems to combat future pandemics.
    Lancet. 2021;398:e2-e6.
    >> Share

  539. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    >> Share

    June 2021
  540. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    >> Share

  541. KUMAR D, Mittal M
    India's COVID-19 emergency: overarching conclusions belie facts.
    Lancet. 2021;397:2465.
    >> Share

  542. SAHA K
    Can India's COVID-19 emergency be fixed without politics?
    Lancet. 2021;397:2465-2466.
    >> Share

  543. VISARIA A, Dharamdasani T
    The complex causes of India's 2021 COVID-19 surge.
    Lancet. 2021;397:2464.
    >> Share

  544. RADHAKRISHNAN N, Gupta DK
    India's COVID-19 response: science first.
    Lancet. 2021;397:2464-2465.
    >> Share

  545. DUTTA R, Kucchal T
    India's pain: beyond COVID-19 case numbers and mortality rates.
    Lancet. 2021;397:2463.
    >> Share

  546. DANIELS JP
    Colombians protest over inequities and health care.
    Lancet. 2021;397:2454.
    >> Share

  547. DUARTE-SALLES T, Prieto-Alhambra D
    Heterologous vaccine regimens against COVID-19.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
    >> Share

  548. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    >> Share

  549. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    >> Share

  550. THE LANCET
    Protecting refugees during the COVID-19 pandemic.
    Lancet. 2021;397:2309.
    >> Share

  551. BARRON GC, Koonin J
    A call to action on UHC commitments.
    Lancet. 2021;397:2335-2336.
    >> Share

  552. USHER AD
    A beautiful idea: how COVAX has fallen short.
    Lancet. 2021;397:2322-2325.
    >> Share

  553. KC S, Ananthakrishnan A, Painter C, Butani D, et al
    Research collaboration is needed to inform quarantine policies for health-care workers.
    Lancet. 2021;397:2334.
    >> Share

  554. ABECASSIS A
    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
    >> Share

  555. SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
    Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
    >> Share

  556. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.
    >> Share

  557. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.
    >> Share

  558. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.
    >> Share

  559. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.
    >> Share

  560. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.
    >> Share

  561. GUBRIUM A, Gubrium E
    Narrative complexity in the time of COVID-19.
    Lancet. 2021;397:2244-2245.
    >> Share

  562. BERGER JS, Connors JM
    Anticoagulation in COVID-19: reaction to the ACTION trial.
    Lancet. 2021;397:2226-2228.
    >> Share

  563. MCLELLAN F
    Kirsten Ostherr: mobilising the translational humanities.
    Lancet. 2021;397:2243.
    >> Share

  564. THE LANCET
    We need a global conversation on the 2020 Olympic Games.
    Lancet. 2021;397:2225.
    >> Share

  565. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
    >> Share

  566. EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
    From routine data collection to policy design: sex and gender both matter in COVID-19.
    Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
    >> Share

  567. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    >> Share

  568. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    >> Share

  569. ZAROCOSTAS J
    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    >> Share

  570. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    >> Share

  571. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    >> Share

  572. USHER AD
    ACT Accelerator strains donors' aid budgets.
    Lancet. 2021;397:2137.
    >> Share

  573. LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
    Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
    >> Share

  574. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
    >> Share

  575. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    >> Share

  576. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    >> Share

    May 2021
  577. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    >> Share

  578. TATUM M
    Cambodia ends controversial COVID-19 restrictions.
    Lancet. 2021;397:2035.
    >> Share

  579. DEVI S
    Yemen's health system has "collapsed", warns UN.
    Lancet. 2021;397:2036.
    >> Share

  580. DEVI S
    800 000 South Sudanese to lose access to health care.
    Lancet. 2021;397:2034.
    >> Share

  581. AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
    India's resurgence of COVID-19: urgent actions needed.
    Lancet. 2021 May 25. pii: S0140-6736(21)01202.
    >> Share


  582. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    >> Share

  583. JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
    Refugee access to COVID-19 vaccines in Lebanon.
    Lancet. 2021;397:1884.
    >> Share

  584. NESAMONEY SN, Darmstadt GL, Wise PH
    Gendered effects of COVID-19 on young girls in regions of conflict.
    Lancet. 2021;397:1880-1881.
    >> Share

  585. ZAROCOSTAS J
    What next for a COVID-19 intellectual property waiver?
    Lancet. 2021;397:1871-1872.
    >> Share

  586. KIRENGA BJ, Byakika-Kibwika P
    Excess COVID-19 mortality among critically ill patients in Africa.
    Lancet. 2021;397:1860-1861.
    >> Share

  587. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.
    >> Share

  588. SAMARASEKERA U
    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    >> Share

  589. HUANG L, Gu X, Wang Y, Huang C, et al
    Long-term effects of COVID-19 on kidney function - Authors' reply.
    Lancet. 2021;397:1807-1808.
    >> Share

  590. WATSON SI
    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.
    >> Share

  591. DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1807.
    >> Share

  592. ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1806-1807.
    >> Share

  593. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.
    >> Share

  594. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.
    >> Share

  595. GENC K
    COVID-19 in Turkey: a nation on edge.
    Lancet. 2021;397:1794-1796.
    >> Share

  596. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.
    >> Share

  597. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    >> Share

  598. HIMMELSTEIN DU, Woolhandler S
    Recovering from Trump: Biden's first 100 days.
    Lancet. 2021;397:1787-1791.
    >> Share

  599. LIU STH, Aberg JA
    Convalescent plasma in patients hospitalised with COVID-19.
    Lancet. 2021 May 14. pii: S0140-6736(21)01064.
    >> Share

  600. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.
    >> Share

  601. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.
    >> Share

  602. MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
    Disease surveillance for the COVID-19 era: time for bold changes.
    Lancet. 2021 May 14. pii: S0140-6736(21)01096.
    >> Share


  603. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00897.
    >> Share

  604. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
    Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Lancet. 2021 May 12. pii: S0140-6736(21)00894.
    >> Share

  605. SHAW RH, Stuart A, Greenland M, Liu X, et al
    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Lancet. 2021 May 12. pii: S0140-6736(21)01115.
    >> Share

  606. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    >> Share

  607. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.
    >> Share

  608. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.
    >> Share

  609. FUJIWARA Y, Onda Y, Hayashi S
    No-fault compensation schemes for COVID-19 medical products.
    Lancet. 2021;397:1707-1708.
    >> Share

  610. HE S, Bala R, Anupindi R, Ranney ML, et al
    Effective supply chain surveillance for PPE.
    Lancet. 2021;397:1706-1707.
    >> Share

  611. DEVI S
    COVID-19 surge threatens health in the Gaza strip.
    Lancet. 2021;397:1698.
    >> Share

  612. THE LANCET
    India's COVID-19 emergency.
    Lancet. 2021;397:1683.
    >> Share

  613. MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
    Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Lancet. 2021;397:1711-1724.
    >> Share

  614. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.
    >> Share

  615. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.
    >> Share

  616. ZAROCOSTAS J
    UK makes massive global health cuts.
    Lancet. 2021;397:1697.
    >> Share

  617. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.
    >> Share

  618. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.
    >> Share

  619. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.
    >> Share

  620. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.
    >> Share


  621. Priorities for COVID-19 research response and preparedness in low-resource settings.
    Lancet. 2021 May 6. pii: S0140-6736(21)00980.
    >> Share

  622. ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
    LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
    Lancet. 2021 May 6. pii: S0140-6736(21)00232.
    >> Share

  623. CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
    What is the right level of spending needed for health and care in the UK?
    Lancet. 2021 May 6. pii: S0140-6736(21)00230.
    >> Share

  624. ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
    Securing a sustainable and fit-for-purpose UK health and care workforce.
    Lancet. 2021 May 6. pii: S0140-6736(21)00231.
    >> Share

  625. MCKEE M, Dunnell K, Anderson M, Brayne C, et al
    The changing health needs of the UK population.
    Lancet. 2021 May 6. pii: S0140-6736(21)00229.
    >> Share

  626. LESHEM E, Wilder-Smith A
    COVID-19 vaccine impact in Israel and a way out of the pandemic.
    Lancet. 2021 May 5. pii: S0140-6736(21)01018.
    >> Share

  627. HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
    Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Lancet. 2021 May 5. pii: S0140-6736(21)00947.
    >> Share

  628. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.
    >> Share

  629. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.
    >> Share

  630. FOGSTAD H
    Women, children, and adolescents in the post-pandemic world.
    Lancet. 2021;397:1620.
    >> Share

  631. HYDE R
    Controversy surrounds Merkel's new lockdown powers.
    Lancet. 2021;397:1610.
    >> Share


  632. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021;397:1637-1645.
    >> Share

    April 2021
  633. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
    Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
    >> Share

  634. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.
    >> Share

  635. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.
    >> Share

  636. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.
    >> Share

  637. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.
    >> Share

  638. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.
    >> Share

  639. THE LANCET
    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.
    >> Share

  640. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.
    >> Share

  641. RASANATHAN K
    Global health and its discontents.
    Lancet. 2021;397:1543-1544.
    >> Share

  642. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
    >> Share

  643. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    >> Share

  644. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
    >> Share

  645. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
    >> Share

  646. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.
    >> Share

  647. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
    >> Share

  648. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
    >> Share

  649. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    >> Share

  650. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
    >> Share

  651. ZAROCOSTAS J
    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    >> Share

  652. THE LANCET
    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    >> Share

  653. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.
    >> Share

  654. CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
    The ultra-connected generation would like to disconnect now.
    Lancet. 2021;397:1350.
    >> Share

  655. ANDREWS K
    Racism is the public health crisis.
    Lancet. 2021;397:1342-1343.
    >> Share

  656. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
    >> Share

  657. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    >> Share

  658. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
    >> Share

  659. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    >> Share

  660. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    >> Share

  661. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    >> Share

  662. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    >> Share

  663. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    >> Share

  664. HE S, Lai D, Lee J
    The medical right to repair: the right to save lives.
    Lancet. 2021;397:1260-1261.
    >> Share

  665. SAMARASEKERA U
    New EU health programme comes into force.
    Lancet. 2021;397:1252-1253.
    >> Share

  666. JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
    10 years of the Syrian conflict: a time to act and not merely to remember.
    Lancet. 2021;397:1245-1248.
    >> Share

  667. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
    >> Share

    March 2021
  668. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    >> Share

  669. SANDERS RW, de Jong MD
    Pandemic moves and countermoves: vaccines and viral variants.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
    >> Share

  670. MYLAN S, Hardman C
    COVID-19, cults, and the anti-vax movement.
    Lancet. 2021;397:1181.
    >> Share

  671. THE LANCET
    COVID-19: building a stronger Europe.
    Lancet. 2021;397:1157.
    >> Share

  672. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.
    >> Share

  673. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
    >> Share

  674. KLUGE H, McKee M
    COVID-19 vaccines for the European region: an unprecedented challenge.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
    >> Share


  675. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    >> Share

  676. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    >> Share

  677. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    >> Share

  678. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    >> Share

  679. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    >> Share

  680. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    >> Share

  681. STRUGNELL R, Wang N
    Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
    Lancet. 2021;397:1037-1039.
    >> Share

  682. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
    COVID-19, community trials, and inclusion.
    Lancet. 2021;397:1036-1037.
    >> Share

  683. HE Z, Ren L, Yang J, Guo L, et al
    Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    Lancet. 2021;397:1075-1084.
    >> Share

  684. JAFFE S
    Biden's first legislative victory: $1.9 trillion for COVID-19.
    Lancet. 2021;397:1047-1048.
    >> Share

  685. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.
    >> Share

  686. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    >> Share

  687. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    >> Share

  688. BOYTON RJ, Altmann DM
    Risk of SARS-CoV-2 reinfection after natural infection.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
    >> Share

  689. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    >> Share

  690. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    >> Share

  691. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
    >> Share

  692. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    >> Share

  693. THE LANCET
    Access to COVID-19 vaccines: looking beyond COVAX.
    Lancet. 2021;397:941.
    >> Share

  694. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    >> Share

  695. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    >> Share

  696. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    >> Share

  697. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
    >> Share

  698. HUNG IFN, Poland GA
    Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
    Lancet. 2021;397:854-855.
    >> Share

  699. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    >> Share

  700. SAMARASEKERA U
    Robin Shattock: novel vaccine developer.
    Lancet. 2021;397:870.
    >> Share

  701. SROUR SA
    Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
    Lancet. 2021;397:861-862.
    >> Share

  702. SOE ZW, Oo MM, Wah KS, Naing AT, et al
    Myanmar's health leaders stand against military rule.
    Lancet. 2021;397:875.
    >> Share

  703. MADAD S, Spencer C
    The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
    >> Share

  704. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    >> Share


  705. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    >> Share

    February 2021
  706. CHAUVIN L
    Peruvian COVID-19 vaccine scandal spreads.
    Lancet. 2021;397:783.
    >> Share

  707. ZAROCOSTAS J
    New WTO leader faces COVID-19 challenges.
    Lancet. 2021;397:782.
    >> Share

  708. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    >> Share

  709. MANISTY C, Otter AD, Treibel TA, McKnight A, et al
    Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
    >> Share

  710. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    >> Share

  711. WHITAKER DK
    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    >> Share

  712. GODDARD AF, Patel M
    The changing face of medical professionalism and the impact of COVID-19.
    Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
    >> Share

  713. SIVA N
    Severe mental illness: reassessing COVID-19 vaccine priorities.
    Lancet. 2021;397:657.
    >> Share

  714. HYDE R
    von der Leyen admits to COVID-19 vaccine failures.
    Lancet. 2021;397:655-656.
    >> Share

  715. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  716. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

  717. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  718. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    >> Share

  719. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    >> Share

  720. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    >> Share

  721. ROBERTSON JFR, Sewell HF, Stewart M
    Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
    >> Share

  722. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    >> Share

  723. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    >> Share

  724. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    >> Share

  725. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    >> Share

  726. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
    >> Share

  727. SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
    Future scenarios for the COVID-19 pandemic.
    Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
    >> Share

  728. MAKONI M
    Tanzania refuses COVID-19 vaccines.
    Lancet. 2021;397:566.
    >> Share

  729. BERWANGER O
    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.
    >> Share

  730. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    >> Share

  731. SINGH NS, Lokot M, Undie CC, Onyango MA, et al
    Research in forced displacement: guidance for a feminist and decolonial approach.
    Lancet. 2021;397:560-562.
    >> Share

  732. THE LANCET
    Improving prisoner health for stronger public health.
    Lancet. 2021;397:555.
    >> Share


  733. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
    >> Share

  734. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
    Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
    >> Share

  735. FONTANET A, Autran B, Lina B, Kieny MP, et al
    SARS-CoV-2 variants and ending the COVID-19 pandemic.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
    >> Share

  736. MARTIN S, Arawi T
    Ensure Palestinians have access to COVID-19 vaccines.
    Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
    >> Share

  737. BURKI T
    Understanding variants of SARS-CoV-2.
    Lancet. 2021;397:462.
    >> Share

  738. ZAROCOSTAS J
    WHO team begins COVID-19 origin investigation.
    Lancet. 2021;397:459.
    >> Share

  739. GORNA R, MacDermott N, Rayner C, O'Hara M, et al
    Long COVID guidelines need to reflect lived experience.
    Lancet. 2021;397:455-457.
    >> Share

  740. WARRELL MJ
    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.
    >> Share

  741. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.
    >> Share

  742. THE LANCET
    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.
    >> Share

  743. CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
    A COVID-19 jab in the right direction.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
    >> Share

  744. KAMPF G, Kulldorff M
    Calling for benefit-risk evaluations of COVID-19 control measures.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
    >> Share

  745. MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
    Breastfeed or be vaccinated-an unreasonable default recommendation.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
    >> Share

  746. JONES I, Roy P
    Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
    >> Share

  747. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
    >> Share


  748. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
    >> Share

  749. FRIESEN P, Caplan AL, Miller JE
    COVID-19 vaccine research and the trouble with clinical equipoise.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
    >> Share

  750. TUYISENGE G, Goldenberg SM
    COVID-19, structural racism, and migrant health in Canada.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
    >> Share

    January 2021
  751. MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
    SARS-CoV-2 serosurveys in low-income and middle-income countries.
    Lancet. 2021;397:353-355.
    >> Share

  752. SAMARASEKERA U
    Fransisca Handy Agung: improving adolescent health in Indonesia.
    Lancet. 2021;397:365.
    >> Share

  753. DANIELS JP
    Health experts slam Bolsonaro's vaccine comments.
    Lancet. 2021;397:361.
    >> Share

  754. THE LANCET
    Health and care workers are owed a better future.
    Lancet. 2021;397:347.
    >> Share

  755. HALLAL PC
    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.
    >> Share

  756. BLAKNEY AK, McKay PF
    Next-generation COVID-19 vaccines: here come the proteins.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
    >> Share

  757. RICHMOND P, Hatchuel L, Dong M, Ma B, et al
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
    >> Share

  758. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
    >> Share


  759. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
    >> Share

  760. SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
    Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
    Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
    >> Share

  761. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    >> Share

  762. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    Lancet. 2021;397:277-278.
    >> Share

  763. NASRALLAH MP, Mourelatos Z, Lee EB
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:277.
    >> Share

  764. GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276.
    >> Share

  765. EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276-277.
    >> Share

  766. AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
    Reaffirming health and safety precautionary principles for COVID-19 in the UK.
    Lancet. 2021;397:274.
    >> Share

  767. MAKONI M
    South Africa responds to new SARS-CoV-2 variant.
    Lancet. 2021;397:267.
    >> Share

  768. BHUYAN A
    India begins COVID-19 vaccination amid trial allegations.
    Lancet. 2021;397:264.
    >> Share

  769. THE LANCET
    COVID-19: the intersection of education and health.
    Lancet. 2021;397:253.
    >> Share

  770. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    >> Share

  771. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    >> Share

  772. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    >> Share

  773. PATEL MS, Phillips CB
    COVID-19 and the moral imagination.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
    >> Share

  774. PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
    An action plan for pan-European defence against new SARS-CoV-2 variants.
    Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
    >> Share

  775. IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
    Preparing for a COVID-19 resurgence in the WHO African region.
    Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
    >> Share

  776. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    >> Share

  777. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    >> Share

  778. WEBSTER P
    COVID-19 highlights Canada's care home crisis.
    Lancet. 2021;397:183.
    >> Share

  779. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    >> Share

  780. JAFFE S
    New leadership at the US CDC.
    Lancet. 2021;397:182.
    >> Share

  781. THE LANCET
    An opportunity for American renewal.
    Lancet. 2021;397:171.
    >> Share

  782. CAVALERI M, Enzmann H, Straus S, Cooke E, et al
    The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
    Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
    >> Share

  783. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    >> Share

  784. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    >> Share

  785. KUSIN S, Choo E
    Parenting in the time of COVID-19.
    Lancet. 2021;397:86.
    >> Share

  786. USHER AD
    Health systems neglected by COVID-19 donors.
    Lancet. 2021;397:83.
    >> Share

  787. KNEEBONE R, Schlegel C
    Thinking across disciplinary boundaries in a time of crisis.
    Lancet. 2021;397:89-90.
    >> Share

  788. COUSINS S
    Polio in Afghanistan: a changing landscape.
    Lancet. 2021;397:84-85.
    >> Share

  789. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
    Lancet. 2021;397:129-170.
    >> Share

  790. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    >> Share

  791. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    >> Share

  792. THE LANCET
    Health as a foundation for society.
    Lancet. 2021;397:1.
    >> Share

  793. DEVI S
    2021: a year of humanitarian need.
    Lancet. 2021;397:12-13.
    >> Share

  794. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.
    >> Share

  795. KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
    Germany's new global health strategy: leaving migrants behind.
    Lancet. 2021;397:20-21.
    >> Share

  796. ROBERTS DE
    Abolish race correction.
    Lancet. 2021;397:17-18.
    >> Share

  797. ROCHON PA, Stall NM, Gurwitz JH
    Making older women visible.
    Lancet. 2021;397:21.
    >> Share

    December 2020
  798. GOODMAN J, de Prudhoe K, Williams C
    UK COVID-19 public inquiry needed to learn lessons and save lives.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
    >> Share

  799. CLAESON M, Hanson S
    COVID-19 and the Swedish enigma.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
    >> Share

  800. HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
    COVID-19 vaccines and women's security.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
    >> Share

  801. SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
    Infectivity of asymptomatic versus symptomatic COVID-19.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
    >> Share

  802. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
    >> Share

  803. WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
    Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
    >> Share

  804. KUNG S, Doppen M, Black M, Hills T, et al
    Reduced mortality in New Zealand during the COVID-19 pandemic.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
    >> Share

  805. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    >> Share

  806. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.
    >> Share

  807. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.
    >> Share

  808. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.
    >> Share

  809. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.
    >> Share

  810. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.
    >> Share

  811. THE LANCET
    Facing up to long COVID.
    Lancet. 2020;396:1861.
    >> Share

  812. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    >> Share

  813. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    >> Share

  814. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    >> Share

  815. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.
    >> Share

  816. THE LANCET
    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.
    >> Share

  817. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    >> Share

  818. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    >> Share

  819. THE LANCET
    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    >> Share

  820. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    >> Share

    November 2020
  821. HERNANDEZ JM
    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.
    >> Share

  822. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.
    >> Share

  823. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.
    >> Share

  824. THE LANCET
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    >> Share

  825. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    >> Share

  826. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    >> Share

  827. HILLS T, Kearns N, Kearns C, Beasley R, et al
    Influenza control during the COVID-19 pandemic.
    Lancet. 2020;396:1633-1634.
    >> Share

  828. THE LANCET
    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.
    >> Share

  829. GRIFFITHS C, Mitchell M, Burnand A
    More support needed for UK charity-funded medical research.
    Lancet. 2020;396:1616-1618.
    >> Share

  830. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
    >> Share

  831. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
    >> Share

  832. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    >> Share

  833. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.
    >> Share

  834. CHANDAN JS
    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    >> Share

  835. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    >> Share

  836. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    >> Share

  837. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    >> Share

  838. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    >> Share

  839. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
    >> Share

  840. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
    >> Share

  841. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
    >> Share

  842. KRIEGER N, Testa C, Hanage WP, Chen JT, et al
    US racial and ethnic data for COVID-19 cases: still missing in action.
    Lancet. 2020;396:e81.
    >> Share

  843. COVIDSURG COLLABORATIVE
    Surgery during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:e79.
    >> Share

  844. VUTHALURU S, Koliyadan SV, Kanniwadi SS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e78.
    >> Share

  845. MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e77.
    >> Share

  846. ALDERMAN J
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e76.
    >> Share

  847. RODRIGUES J, Chan JK, Issa F
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e75.
    >> Share

  848. SHANTHANNA H, Uppal V
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e74.
    >> Share

  849. HAMID HKS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e73.
    >> Share

  850. HUNG IF, Yuen KY
    Early triple antiviral therapy for COVID-19 - Authors' reply.
    Lancet. 2020;396:1488.
    >> Share

  851. LEE N, Ison M, Dunning J
    Early triple antiviral therapy for COVID-19.
    Lancet. 2020;396:1487-1488.
    >> Share

  852. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Lancet. 2020;396:1486-1487.
    >> Share

  853. LODGE A
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1486.
    >> Share

  854. CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1485-1486.
    >> Share

  855. HOFFMANN C, Wolf E
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  856. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Lancet. 2020;396:1484-1485.
    >> Share

  857. GEORGE TP
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  858. DZAU VJ, Balatbat C
    Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
    Lancet. 2020;396:1469-1471.
    >> Share

  859. THE LANCET
    COVID-19 in Latin America: a humanitarian crisis.
    Lancet. 2020;396:1463.
    >> Share

  860. BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
    Institutional versus home isolation to curb the COVID-19 outbreak.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
    >> Share

  861. WILDER-SMITH A, Cook AR, Dickens BL
    Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
    >> Share

  862. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
    >> Share

  863. HOPKINS C, Smith B
    Widespread smell testing for COVID-19 has limited application.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
    >> Share

  864. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Widespread smell testing for COVID-19 has limited application - Authors' reply.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
    >> Share

    October 2020
  865. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.
    >> Share

  866. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.
    >> Share

  867. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.
    >> Share

  868. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.
    >> Share

  869. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.
    >> Share

  870. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.
    >> Share

  871. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.
    >> Share

  872. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.
    >> Share

  873. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.
    >> Share

  874. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
    >> Share

  875. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    >> Share

  876. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    >> Share

  877. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    >> Share

  878. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    >> Share

  879. THE LANCET
    Global health: time for radical change?
    Lancet. 2020;396:1129.
    >> Share

  880. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    >> Share

  881. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    >> Share

  882. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    >> Share

  883. WARD BJ, Makarkov A, Seguin A, Pillet S, et al
    Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (>/=65 years): two multicentre, randomised phase 3 trials.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32014.
    >> Share

  884. TREGONING JS
    First human efficacy study of a plant-derived influenza vaccine.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32010.
    >> Share

  885. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    >> Share

  886. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    >> Share

  887. BLUKACZ A, Cabieses B
    COVID-19: leaving no one behind in Latin America.
    Lancet. 2020;396:1070.
    >> Share

  888. CHARLIER P, Varison L
    Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
    Lancet. 2020;396:1069-1070.
    >> Share

  889. KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
    Cancer and COVID-19 - Authors' reply.
    Lancet. 2020;396:1067-1068.
    >> Share

  890. MALEK AE, Raad II, Jabbour E
    Cancer and COVID-19.
    Lancet. 2020;396:1066-1067.
    >> Share

  891. MORIS D, Tsilimigras DI, Schizas D
    Cancer and COVID-19.
    Lancet. 2020;396:1066.
    >> Share

  892. GROSS R, Conzelmann C, Muller JA, Reister F, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1065-1066.
    >> Share

  893. CUMMINGS MJ, O'Donnell MR
    Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Lancet. 2020;396:1064.
    >> Share

  894. SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic.
    Lancet. 2020;396:1064-1065.
    >> Share

  895. PIOVANI D, Bonovas S
    Study of critically ill patients with COVID-19 in New York City.
    Lancet. 2020;396:1064.
    >> Share

  896. CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
    COVID-19, comics, and the visual culture of contagion.
    Lancet. 2020;396:1061-1063.
    >> Share

  897. COUSINS S
    2.5 million more child marriages due to COVID-19 pandemic.
    Lancet. 2020;396:1059.
    >> Share

  898. THE LANCET
    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    >> Share

  899. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    >> Share

  900. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    >> Share

  901. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    >> Share

  902. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
    >> Share

  903. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
    >> Share

  904. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
    >> Share

  905. BOZORGMEHR K
    Power of and power over COVID-19 response guidelines.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
    >> Share

  906. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    >> Share


  907. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    >> Share

  908. DENING KH, Lloyd-Williams M
    Minimising long-term effect of COVID-19 in dementia care.
    Lancet. 2020;396:957-958.
    >> Share

  909. WANG Y, Gu X, Xu J, Cao B, et al
    Remdesivir and COVID-19 - Authors' reply.
    Lancet. 2020;396:954.
    >> Share

  910. WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
    Remdesivir and COVID-19.
    Lancet. 2020;396:953-954.
    >> Share

  911. EDWARDS JK, Cole SR, Adimora AA
    Remdesivir and COVID-19.
    Lancet. 2020;396:953.
    >> Share

  912. GLAUS MJ, Von Ruden S
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  913. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    >> Share

  914. THE LANCET
    Building a resilient NHS, for COVID-19 and beyond.
    Lancet. 2020;396:935.
    >> Share

    September 2020
  915. CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
    Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
    >> Share

  916. STRATHDEE SA, Davies SC, Marcelin JR
    Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
    >> Share

  917. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.
    >> Share

  918. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.
    >> Share

  919. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.
    >> Share

  920. JAFFE S
    Media reports reveal political interference at the US CDC.
    Lancet. 2020;396:875.
    >> Share

  921. THE LANCET
    COVID-19 in India: the dangers of false optimism.
    Lancet. 2020;396:867.
    >> Share

  922. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.
    >> Share

  923. BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
    Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
    >> Share

  924. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  925. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    >> Share

  926. HAN E, Tan MMJ, Turk E, Sridhar D, et al
    Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
    Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
    >> Share

  927. LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
    >> Share

  928. BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
    >> Share

  929. PEIRIS M, Leung GM
    What can we expect from first-generation COVID-19 vaccines?
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
    >> Share

  930. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.
    >> Share

  931. KLEINERT S, Horton R
    Preprints with The Lancet are here to stay.
    Lancet. 2020;396:805.
    >> Share

  932. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    >> Share

  933. GALEA S, Ettman CK, Abdalla SM
    Access to health care and the 2020 US election.
    Lancet. 2020;396:803-805.
    >> Share


  934. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
    >> Share

  935. SLIWA K, Yacoub M
    Catalysing the response to NCDI Poverty at a time of COVID-19.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
    >> Share

  936. THE LANCET
    Global collaboration for health: rhetoric versus reality.
    Lancet. 2020;396:735.
    >> Share

  937. OLDENBURG CE, Doan T
    Azithromycin for severe COVID-19.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
    >> Share

  938. FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
    Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
    >> Share

  939. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
    >> Share

  940. LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
    >> Share

    August 2020
  941. FISHER DA, Carson G
    Back to basics: the outbreak response pillars.
    Lancet. 2020;396:598.
    >> Share

    April 2020
  942. CHENG KK, Lam TH, Leung CC
    Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity.
    Lancet. 2020 Apr 16. pii: S0140-6736(20)30918.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016